Open AccessDiabetes Insipidus After Discontinuation of Vasopressin Infusion for Treatment of Shock
Author(s) -
Hannah Ferenchick,
Nail Cemalovic,
Nadia Ferguson,
Peter V. Dicpinigaitis
Publication year - 2019
Publication title -
critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.002
H-Index - 271
eISSN - 1530-0293
pISSN - 0090-3493
DOI - 10.1097/ccm.0000000000004045
Subject(s) - medicine , diabetes insipidus , vasopressin , discontinuation , anesthesia , shock (circulatory) , surgery
Vasopressin has achieved common usage for the treatment of catecholamine-requiring and catecholamine-resistant shock. Diabetes insipidus is a syndrome characterized by excretion of abnormally large volumes of dilute urine. To date, very few reports of diabetes insipidus after discontinuation of vasopressin infusion have been published; the majority of previous reports describe neurosurgical patients. The purpose of the present study was to investigate the occurrence rate of diabetes insipidus after discontinuation of vasopressin infusion among patients treated with vasopressin infusion for shock.